News Focus
News Focus
icon url

$Pistol Pete$

03/19/17 4:26 PM

#123520 RE: WALL STREET KID #123473

$RSII 3 Months Chart

icon url

$Pistol Pete$

03/19/17 4:27 PM

#123521 RE: WALL STREET KID #123473

$INOH 3 Months Chart

icon url

$Pistol Pete$

03/19/17 4:27 PM

#123522 RE: WALL STREET KID #123473

$QSIM 3 Months Chart

icon url

$Pistol Pete$

03/19/17 4:27 PM

#123523 RE: WALL STREET KID #123473

$TXTM 3 Months Chart

icon url

$Pistol Pete$

03/19/17 4:28 PM

#123524 RE: WALL STREET KID #123473

$MYDX 3 Months Chart

icon url

$Pistol Pete$

03/19/17 4:28 PM

#123525 RE: WALL STREET KID #123473

$MMEX 3 Months Chart

icon url

$Pistol Pete$

03/19/17 4:28 PM

#123526 RE: WALL STREET KID #123473

$BMGP 3 Months Chart

icon url

$Pistol Pete$

04/03/17 6:13 PM

#125258 RE: WALL STREET KID #123473

$MMEX Current Report Filing (8-k)

Source: Edgar (US Regulatory)

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________

FORM 8-K
CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OFTHE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 31, 2017
_________________

MMEX RESOURCES CORPORATION
(Exact name of registrant as specified in its charter)

Nevada

333-152608

26-1749145
(State of incorporation)

(Commission File Number)

(IRS Employer Identification Number)

3616 Far West Blvd., #117-321
Austin, Texas 78731
(Address of principal executive offices)

Registrant's telephone number, including area code: (855) 880-0400

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the reporting obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act

o Soliciting material pursuant to Rule 14a-12 of the Exchange Act

o Pre-commencement communications pursuant to Rule 14d-2(b) Exchange Act

o Pre-commencement communications pursuant to Rule 13e-4(c) Exchange Act





Item 1.01 Entry into a Material Definitive Agreement

In our report on Form 8-K filed on March 10, 2017, MMEX Resources Corporation (the “Company” or “we”) reported that it had entered into an agreement with Maple Resources Corporation (“Maple”), a related party, to acquire all of Maple’s right, title and interest (the “Rights”) in plans to build a $450 million, 50,000 barrels per day capacity crude oil refinery in Pecos County, Texas (the “ Refinery Transaction” or the “Project”). We also reported that pursuant to the Refinery Transaction, the Company had issued to Maple a first tranche of 1,500,000,000 shares of common stock to be issued on March 4, 2017 and that a second tranche of 5,500,000,000 shares (subject to adjustment) were to be issued once the Company’s Articles of Incorporation were amended to increase the number of authorized shares of common stock.

In connection with the amendment to the Company’s Articles of Incorporation, Maple has agreed to waive its right to receive the second tranche of 5,500,000,000 shares of common stock.

Item 5.03 Amendment of Articles of Incorporation or Bylaws; Change in Fiscal Year

Our board of directors and the holders of a majority of the outstanding shares of Company’s common stock have approved an amendment to the Articles of Incorporation to provide for the increase in authorized shares of common stock from 3,000,000,000 to 5,000,000,000 common shares. In addition, the Articles of Incorporation have been amended to provide for two classes of common shares: (i) Class A Shares, having one vote per share, and (ii) Class B Shares, with 10 votes per share. All of the outstanding shares of Common Stock will be reclassified as Class A Shares, except that all of the shares issued to Maple in connection with the Refinery Transaction will be Class B Shares. Other than the provisions of the voting rights, the two classes of shares have equal terms and conditions. Further, in view of the number of amendments in the Company’s history, the Articles of Incorporation have been amended and restated for all of the foregoing provisions. A copy of the amended and restated Articles of Incorporation is filed as Exhibit 3.1 to this report on Form 8-K.

Further, the Bylaws of the Company have been amended and restated to include all necessary conforming changes for the Company’s capital structure, and other required updating. A copy of the amended and restated Bylaws is filed as Exhibit 3.2 to this report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

3.1 Amended and Restated Articles of Incorporation


3.2 Amended and Restated Bylaws


2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MMEX Resources Corporation

Date: April 3, 2017 By: /s/ Jack W. Hanks


Jack W. Hanks
President and Chief Executive Officer


3
icon url

$Pistol Pete$

05/22/17 4:38 PM

#129787 RE: WALL STREET KID #123473

$MYDX MyDx Reports First Quarter Results

May 22, 2017
OTC Disclosure & News Service

-

MyDx Reports First Quarter Results

Strong Performance of CannaDx Drives Sales Growth, Leading To Positive Cash-Flow Generation

SAN DIEGO, CA--(Marketwired - May 22, 2017) - MyDx, Inc. (OTCQB: MYDX), a rapidly growing science and technology company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, announces 1Q 2017 results and management analysis.

Financial Results

Revenue and client deposits increased to ~$264k, up ~50% from the same quarter in the previous year, on strong product & licensing demand

Revenue was lifted by increasing demand for CannaDx™ Sensor, which in turn was brought on by greater consumer awareness of MyDx products and services
MyDx sold out of its signature Handheld Analyzer on stronger than expected demand leading to a backlog of orders and customer deposits that are currently being filled
For the first time in company history, the company is cash-flow positive with ~$30k in operating cash flows vs. (~$210k) from the same quarter in the previous year

The company demonstrated its ability to generate sufficient positive cash flow to maintain and grow its core business operations
Combined with cash flows from investing and financing activities, the company generated net positive cash flow of ~$100k, which strengthened the overall balance sheet by increasing cash on hand to ~$135k
The company intends to make substantial investments in marketing and sales to grow the business and execute on its growth strategy, which may impact cash-flow characteristics going forward
Satisfied ~$250k in debt used to finance company operations and support growth initiatives

The company continued its march to relieve itself of toxic variable rate debt obligations, which has significantly reduced its yearly debt burden and brought a level of stability to the stock price
The company will continue to seek alternative financing options to support the growth of its business segments
Operating Results

MyDx diversified its business operations by creating an ecosystem of hardware, software and related services that serves to generate consumer-centric data that can then be leveraged to develop, deploy and track additional consumer products and services
The company spent time and R&D on the creation of the MyDx ECO Smart Pen, a blue-tooth enabled delivery pen capable of actively and passively tracking consumption habits
The company also created MyDx360, its first revenue stream developed by MyDx data insights, which is a SAAS-based community engagement platform designed to help entrepreneurs launch and track cannabis brands at a low cost
The company intends to close its first big customer under its newly created revenue streams in Q2 and will announce it when terms are fully negotiated
MyDx continued to build out its sensory technologies leading to the latest release of MyDx 2.0, an upgraded chemical analyzer that can now accommodate multiple sensors

MyDx 2.0 handheld devices have been upgraded to allow for new sensors to be interchanged seamlessly with the CannaDx Sensor
AeroDx Sensors will be the first of three anticipated digital sensors to be launched into the market and represents the first versatile sensor with applications beyond cannabis that will allow consumers to test what they eat, drink and inhale.
About MyDx, Inc.
MyDx, Inc. (OTCQB: MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user's hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology. The MyDx AquaDx®, OrganaDx™ and CannaDx™ sensors are now commercialized, and the AeroDx® application is next in line. All sensors will be compatible with a MyDx App that empowers consumers to live a healthier life by revealing the chemical composition of what they eat, drink and inhale. For more information, please visit www.cdxlife.com.

Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3141665
MyDx, Inc.
MyDx Shareholder Communications
800-814-4550 ext. 4
ir@cdxlife.com


Copyright © 2017 Marketwired. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.